ProMetic in pact with Novozymes

ProMetic Life Sciences and Denmark’s Novozymes have joined forces in a strategic alliance for the purification of albumin-fusion proteins using a synthetic-ligand affinity adsorbent developed by ProMetic (TSX:PLI). The purification technology has been designed for the rapid and cost-effective development of Novozymes’ albufuse albumin-fusion molecules. Novozymes (OMX:NZYM B) is the world’s largest producer of industrial [...]